Multiplex analysis of intratumoural immune infiltrate and prognosis in patients with stage II–III colorectal cancer from the SCOT and QUASAR 2 trials: a retrospective analysis

Guardado en:

Detalles Bibliográficos
Publicado en:	Lancet Oncology vol. 25, no. 2 (Feb 2024), p. 198
Autor principal:	Frei, Anja L
Otros Autores:	McGuigan, Anthony, Ritik R A K Sinha, Jabbar, Faiz, Gneo, Luciana, Tomasevic, Tijana, Harkin, Andrea, Iveson, Tim, Saunders, Mark P, Oien, Karin A, Noori Maka, Pezzella, Francesco, Campo, Leticia, Browne, Molly, Glaire, Mark, Kildal, Wanja, Danielsen, Havard E, Hay, Jennifer, Edwards, Joanne, Sansom, Owen, Kelly, Caroline, Tomlinson, Ian, Kerr, Rachel, Kerr, David, Domingo, Enric, Church, David N, Glimelius, Bengt, Ismail Gonegur, Hay, Jen, Iveson, Timothy, Jaeger, Emma, Morgan, Hannah, Oien, Karen, Orange, Clare, Palles, Claire, Campbell Roxburgh, Koelzer, Viktor H
Publicado:	Elsevier Limited
Materias:	Clinical trials Cytotoxicity Medical prognosis Foxp3 protein Immunotherapy Quality control Lymphocytes T Prognosis Epithelium CD20 antigen Colorectal carcinoma Medical research Oxaliplatin Bevacizumab Colorectal cancer Chemotherapy Patients CD8 antigen Cancer Cytokeratin Meta-analysis Targeted cancer therapy Monoclonal antibodies
Acceso en línea:	Citation/Abstract Full Text Full Text - PDF
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!